文献速递临床试验与 GCP

头戴式装置七氟烷吸入麻醉与丙泊酚静脉麻醉在膝关节镜手术中的随机对照试验方案

Comparison of sevoflurane inhalational anesthesia using a headgear device versus propofol intravenous anesthesia in arthroscopic surgery-study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2026-03-03

本研究为单中心随机对照试验方案,拟纳入96例膝关节镜手术患者,1:1随机分为七氟烷吸入组(经专利头戴式全封闭装置给药)与丙泊酚靶控输注组,均保留自主呼吸。主要结局为术中呼吸抑制发生率,次要结局包括术中低血压、心动过缓、体动、咳嗽及术后24小时头痛、躁动、疼痛、恶心呕吐、恢复质量(QoR-15)、住院时长与费用。

要点

  • 比较全封闭头戴式七氟烷吸入与丙泊酚静脉麻醉在膝关节镜手术中的效果。
  • 主要结局为术中呼吸抑制发生率,两组均保留自主呼吸。
  • 次要结局涵盖术中不良事件及术后24小时恢复指标与住院费用。

核心结论

  • 该方案旨在评估全封闭吸入麻醉系统在膝关节镜手术中对比全静脉麻醉对术中自主呼吸及术后恢复的影响,并判断哪种麻醉方式更安全舒适。

研究设计与样本

  • 单中心随机对照试验,共96例受试者按1:1随机分配至七氟烷组或丙泊酚组。
  • 七氟烷组经专利头戴式全封闭装置行诱导与维持;丙泊酚组经静脉靶控输注行诱导与维持。
  • 试验注册于中国临床试验注册中心,注册号ChiCTR2200057229,注册日期2022年3月4日。

关键数值与推荐

  • 主要结局为术中呼吸抑制发生率。
  • 次要结局包括术中低血压、心动过缓、体动、咳嗽发生率,以及术后24小时内头痛和躁动的发生。
  • 术后24小时采用数字评分量表(NRS)评估疼痛、恶心呕吐严重程度,采用恢复质量-15评分(QoR-15)评估恢复质量,并记录住院时长与相关住院费用。

临床怎么用

  • 若该方案证实全封闭头戴式七氟烷吸入麻醉在保留自主呼吸下安全有效,可为膝关节镜日间手术提供避免气管插管的麻醉选择。

局限性

  • 研究为单中心设计,样本量96例,结果外推需谨慎。
  • 原文未报告盲法、分配隐藏及样本量计算依据等信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arthroscopic knee surgery (AKS) is a widely performed day procedure used for both the diagnosis and treatment of various knee-related conditions. Although this surgical approach is less invasive compared to traditional methods, it still necessitates effective anesthesia management. Conventional anesthetic techniques, such as spinal anesthesia and peripheral nerve blocks, often fall short in facilitating rapid recovery after day surgery, primarily due to prolonged postanesthesia recovery times and the potential for associated complications. In contrast, general anesthesia that preserves spontaneous respiration may present a more advantageous alternative, as it avoids the complications associated with tracheal intubation. This study aims to evaluate the effects of inhalation anesthesia in comparison to total intravenous anesthesia, both with preserved spontaneous respiration, on intraoperative adverse respiratory events and postoperative recovery. To prevent leakage of volatile anesthetics, we will utilize a headgear device designed for fully enclosed inhalation anesthesia that enables patients to maintain spontaneous respiration throughout the procedure. The findings of this research are intended to provide reliable evidence to support the broader clinical application of this anesthesia technique in the context of arthroscopic knee surgery. METHODS: This study is designed as a randomized clinical trial conducted at a single center. A total of 96 participants will be randomly assigned to one of two groups: the sevoflurane group or the propofol group, with a 1:1 allocation ratio. In the sevoflurane group, sevoflurane will be utilized for the induction and maintenance of anesthesia, administered through our patented equipment. The propofol group will receive propofol via intravenous target-controlled infusion for both the induction and maintenance of anesthesia. The primary outcome measure is the incidence of intraoperative respiratory depression. Secondary outcome measures include the incidence of intraoperative hypotension, bradycardia, somatic responses, and coughing, as well as the occurrence of postoperative headache and agitation within 24 h following surgery. Additionally, we will evaluate the severity of postoperative pain, nausea, and vomiting using a numerical rating scale (NRS) at the same postoperative interval. And the quality of recovery will be measured with the Quality of Recovery-15 score (QoR-15) at 24 h post-surgery. The length of hospital stay and associated hospitalization costs will also be documented. DISCUSSION: The objective of our study is to assess the potential benefits of our fully enclosed inhalational anesthesia system in patients undergoing AKS. We will specifically examine the effects of inhalational anesthesia compared to total intravenous anesthesia on intraoperative spontaneous respiration and postoperative recovery. Our aim is also to determine which anesthesia modality offers greater safety and comfort for surgical patients. TRIAL REGISTRATION: China Clinical Trial Register ChiCTR2200057229. Registered on 4 March 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zuo D, Yang G, Hao G, et al. Comparison of sevoflurane inhalational anesthesia using a headgear device versus propofol intravenous anesthesia in arthroscopic surgery-study protocol for a randomized controlled trial. Trials. 2026. PMID: 41772657. doi:10.1186/s13063-026-09602-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。